The Moderna and Replimune approvals are positive signs that the new leadership may be mounting a much-needed turnaround. Dr. Mikhail recently announced several initiatives to streamline the FDA’s ...
On 5 August, the US Food and Drug Administration (FDA) granted approval to Moderna’s mRNA-based flu vaccine, mFLUSIVA, for adults aged 50–64, and accelerated approval for adults 65 and older. Moderna ...
President Trump is calling for immunizations for measles, mumps and rubella to be given in individual jabs in three different appointments instead of the standard combination shot.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results